Irinotecan Upregulates Fibroblast Growth Factor Receptor 3 Expression in Colorectal Cancer Cells, Which Mitigates Irinotecan-Induced Apoptosis

This publication has 30 references indexed in Scilit:

• 2-Deprenyl-Rheediaxanthone B Isolated from Metaxya rostrata Induces Active Cell Death in Colorectal Tumor Cells
  PLOS ONE, 2013
• Differential Effects of Polymorphic Alleles of FGF Receptor 4 on Colon Cancer Growth and Metastasis
  Cancer Research, 2012
• Fibroblast Growth Factor Receptor-3 (FGFR-3) Regulates Expression of Paneth Cell Lineage-specific Genes in Intestinal Epithelial Cells through both TCF4/β-Catenin-dependent and -independent Signaling Pathways
  Journal of Biological Chemistry, 2011
• Overview of Systemic Therapy for Colorectal Cancer
  Clinics in Colon and Rectal Surgery, 2009
• Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes
  Clinical Cancer Research, 2008
• Topoisomerase I inhibitors: camptothecins and beyond
  Nature Reviews Cancer, 2006
• Mutual amplification of apoptosis by statin‐induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells
  British Journal of Pharmacology, 2004
• Fibroblast growth factors in epithelial repair and cytoprotection
  Philosophical Transactions of the Royal Society B: Biological Sciences, 2004
• Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex.
  2003
• Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks
  Nature Cell Biology, 2003